Q3 EBITDA Beats and FY Revenue, EBITDA Outlook Tops Estimates
CTEV sits 97% above its 52-week low of $11.5.
Summary
Claritev posted Q3 adjusted EBITDA of $162 million, ahead of the $155.8 million IBES estimate, on revenue of $268.3 million, and guided FY revenue to $1,038-1,043 million versus $1,014 million expected. FY adjusted EBITDA guidance of $625-630 million also clears the $615.4 million consensus, and capex is set at $165-170 million. The company raised its 2026 outlook and sees preliminary 2027 revenue of $1.1 billion. The top-line beat and raised outlook are the story here, but the quarter still carried a $61.789 million net loss, a loss per share of $3.64 and $80.029 million pretax loss, so profitability remains pressured. This follows a Q2 that beat expectations but disclosed an unremediated material weakness and an ongoing DOJ civil probe, and comes after Ares-affiliated holders added roughly $1.68 million of stock in late October.
At the time of this announcement, CTEV was trading at $22.71 on NYSE in the Finance sector, with a market capitalization of approximately $384.9M. The 52-week trading range was $11.50 to $73.68. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.